Understanding how FRNK affects lung fibrosis in patients with IPF
The Impaired FRNK in IPF
This study is looking at a protein called FRNK to understand why it doesn't work properly in people with idiopathic pulmonary fibrosis (IPF), which causes serious lung scarring, and the researchers hope to find new ways to help treat this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10842265 on NIH RePORTER |
What this research studies
This research investigates the role of a protein called FRNK in idiopathic pulmonary fibrosis (IPF), a serious lung disease characterized by excessive scarring. The study aims to uncover how FRNK, which normally helps to control fibrosis, is downregulated in patients with IPF, leading to increased lung damage. By examining the mechanisms behind this downregulation and its effects on lung cells, the researchers hope to identify new therapeutic targets for treating IPF. The approach includes studying cell behavior in laboratory settings and using animal models to understand the underlying biological processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis.
Not a fit: Patients with other forms of lung disease or those without a diagnosis of pulmonary fibrosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that slow down or reverse lung fibrosis in patients with IPF.
How similar studies have performed: Previous research has shown promising results in understanding the role of similar proteins in fibrosis, suggesting that this approach could yield valuable insights.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Ding, Qiang — University of Alabama at Birmingham
- Study coordinator: Ding, Qiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.